CXCL8 and cystic fibrosis: The serum concentration of other inflammatory factors analyzed in the present study shows a clear, although non-significant, trend towards a reduction in the group of patients treated with aminoacidic supplementation, in particular in IL-8, a cytokine whose role has been extensively studied in CF patients [21,24,25].